Build the foundation before scaling.
For investors
One BIOS intelligence. Two products and a research environment.
Health Memory stores verifiable data, BIOS Intelligence analyses trends, and Personal, Clinical and research modules use the same results.
Forecasts and funding round terms are disclosed separately. This is not a public offer.
Shared data, algorithm and controls.
Multiple channels. One infrastructure.
Clinics, laboratories, pharma and integrators.
Why BIOS
Longitudinal data and proprietary analysis create value
One technology foundation supports products for individuals, clinics and research partners.
Fragmented data obscures changes over time
Facts remain scattered across documents, systems and individual visits.
Health Memory preserves verifiable facts
The source, date and version stay with the data.
BIOS Intelligence analyses changes
Identifies patterns and generates testable AI hypotheses.
Personal and Clinical use the same results
Individuals receive explanations; doctors receive evidence to verify.
Control is built into the product
Versions, access rights, limitations and the doctor’s decision.
Longitudinal data supports a research environment
From changes in an individual’s health to testing patterns within populations, under separate protocols and consents.
Business model
Several models. One foundation.
Launch depends on readiness and a lawful basis.
Individuals
BIOS Personal subscription
Health programmes
Clinic selection
Clinics
BIOS Clinical
Pilot and implementation
Monitoring programmes
Partners
Data integration
Joint programmes
BIOS services
Pharma and research
Research with consent
Data over time
Conducting studies
Current stage
What matters now
Architecture, validation, market entry and risk management.
BIOS Intelligence + Health Memory
Longitudinal analysis of data with sources and versions.
The path to a clinical pilot
Predefined stages and criteria.
The first two products
BIOS Personal and BIOS Clinical.
Due diligence readiness
Clear separation between what is claimed, implemented and substantiated.
Capital priorities
Fundamental risks first
The precise allocation is disclosed in funding round materials.
Clinical practice and safety
Expert review, physician involvement and quality control.
Engineering
Data platform, reliability, security and integrations.
Pilots
Clinical implementation and a repeatable launch process.
Distribution
BIOS Personal, clinics and partner channels after product validation.
Investor materials
Request materials
Please specify your fund, focus and stage of interest.